Ledifos Tablets

Ledifos Tablets Specification

Indication
Chronic Hepatitis C Virus (HCV) infection

Dosage Form
Tablet

Origin
India

Salt Composition
Ledipasvir 90mg & Sofosbuvir 400mg

Enzyme Types
Ledifos Tablets

Feature
Fixed-dose combination antiviral therapy

Ingredients
Ledipasvir, Sofosbuvir, excipients

Application
Used in combination therapy for HCV genotype 1, 4, 5, and 6 infections in adults

Physical Color/Texture
Film-coated, oval, yellow tablet

Fermentation Smell
Odorless

Storage Instructions
Cool & Dry Place

Shelf Life
24 months

Therapeutic Class
Antiviral Agents

Prescription Status
Prescription only

Strength
90 mg/400 mg per tablet

Common Side Effects
Fatigue, headache, nausea, insomnia

Administration Route
Oral

Contraindications
Hypersensitivity to Ledipasvir, Sofosbuvir, or any excipients

Use in Pregnancy
Use only if clearly needed and prescribed

Packaging Size
28 tablets per bottle

Product Code
Ledifos

Intended Patients
Adults with no or mild cirrhosis

Ledifos Tablets Trade Information

Minimum Order Quantity
100 Packs

Supply Ability
100 Packs Per Day

Delivery Time
2 Days

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Main Domestic Market
All India

About Ledifos Tablets

Ledipasvir is used in the treatment of chronic hepatitis C virus (HCV) infection. Ledipasvir is an antiviral medication. It works by lowering a load of hepatitis C virus in the body and removing the virus from the blood over a period of time.

Effective Combination Therapy for HCV

Ledifos tablets utilize a combination of Ledipasvir and Sofosbuvir, offering a potent oral therapy for chronic Hepatitis C Virus (HCV) infections in adults. This antiviral agent targets multiple genotypes, providing a versatile treatment option for patients with no or mild cirrhosis. Used as part of combination therapy, it assists in achieving sustained virological response, significantly improving patient outcomes.

Quality Assured and Convenient Packaging

Each Ledifos package contains 28 film-coated tablets in a securely sealed bottle, ensuring quality and hygiene. The tablets are odorless and have a shelf life of up to 24 months. With its easy oral administration and prescription-only availability, patients are ensured of both safety and efficacy throughout the treatment course.

FAQ's of Ledifos Tablets:

Q: How should Ledifos Tablets be administered for chronic Hepatitis C infection?

A: Ledifos Tablets are taken orally, as directed by your healthcare provider. Typically, one tablet is taken daily at the same time, with or without food. Adherence to the prescribed dosing schedule is crucial for optimal results.

Q: What are the main benefits of using Ledifos Tablets in HCV treatment?

A: Ledifos offers a fixed-dose combination therapy that effectively targets HCV genotypes 1, 4, 5, and 6 in adults. The dual antiviral agents increase the likelihood of clearing the virus and improve the chances of achieving sustained virological response.

Q: When should Ledifos not be used?

A: Do not use Ledifos if you have a known hypersensitivity to Ledipasvir, Sofosbuvir, or any of the tablet's excipients. Always consult your doctor for a full review of contraindications prior to starting treatment.

Q: What common side effects might occur while taking Ledifos Tablets?

A: Patients may experience side effects such as fatigue, headache, nausea, or insomnia. If side effects are bothersome or severe, contact your healthcare provider promptly.

Q: Where should Ledifos Tablets be stored?

A: Ledifos Tablets must be kept in a cool and dry place, away from direct sunlight and moisture. Always keep the bottle tightly closed and out of reach of children.

Q: What is the process for obtaining Ledifos Tablets?

A: Ledifos Tablets require a valid prescription from a qualified healthcare provider. Once prescribed, they can be obtained from authorized suppliers, exporters, or traders, especially in India.

Q: Is Ledifos safe to use during pregnancy?

A: Ledifos should be used in pregnancy only if clearly needed and prescribed by a healthcare professional, after weighing the potential benefits against potential risks.

Tell us about your requirement